Digitalis, catecholamines and vasodilators in heart failure
Mager, G.; Höpp, H.W.; Hilger, H.H.
Der Internist 33(10): 631-638
1992
ISSN/ISBN: 0020-9554 PMID: 1428681 Document Number: 393276
Document emailed within 1 workday
Related Documents
Slany, J. 1987: Do vasodilators help in chronic heart failure? Wiener Klinische Wochenschrift 99(5): 139-144Assmann, I. 1990: The extension of heart failure therapy with vasodilators Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(12): 352-356
Bühler, F.R.; Amann, F.W. 1979: Vasodilators and diuretics, basic therapy for hypertensive heart failure Schweizerische Rundschau für Medizin Praxis 68(33): 1049-1052
Bolognesi, R.; Manca, C. 1991: Digitalis and heart failure Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 6(2): 241-247
Drexler, H. 1987: Regional perfusion in heart failure. Changed distribution of blood flow caused by vasodilators Fortschritte der Medizin 105(24): 464-466
Markiewicz, K.; Górski, L.; Broks-Bratkowska, B.; Cholewa, M. 1993: Effect of treatment with vasodilators on physical exercise tolerance in patients with chronic congestive heart failure Polski Tygodnik Lekarski 48(3-4): 61-64
Heinzl, B.S. 1986: 200 years of digitalis. Controversies in the therapy of heart failure Medizinische Monatsschrift für Pharmazeuten 9(2): 42-46
Patterson, D.F.; Abt, D.A.; Detweiler, D.K.; Knight, D.H.; Buchanan, J.W.; Pyle, R.L. 1973: On digitalis glycosides in treatment of heart failure: criticism and reply Veterinary Medicine-Small Animal Clinician 68(7): 708 Passim
Dickstein, K.; Larsen, A.I. 1991: Digitalis therapy in patients with heart failure and sinus rhythm Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3180-3182
Daly, P.A.; Sole, M.J. 1990: Myocardial catecholamines and the pathophysiology of heart failure Circulation 82(2): I35-I43
Komarov, F.I.; Ol'binskaia, L.I. 1982: Debatable questions of digitalis therapy in the early stages of heart failure Terapevticheskii Arkhiv 54(11): 106-110
Lehmann, M.; Keul, J.; Löllgen, H.; Just, H. 1981: Plasma catecholamines and hemodynamics in left heart failure Zeitschrift für Kardiologie 70(4): 238-244
Tobin, J.R. 1978: The treatment of congestive heart failure. Digitalis glycosides are still the primary mode of therapy Archives of Internal Medicine 138(3): 453-454
Pasini, E.; Opasich, C.; Aquilani, R. 2000: Catecholamines and beta-blockers in heart failure: some physiopathological and pharmacological reflections Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 1(2): 171-179
Daum, S.; Goerg, R.; Mack, D.; Wang, D. 1984: Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection Praxis und Klinik der Pneumologie 38(9): 406-411
Ko, Y.S.; Yang, S.Y.; Yian, W.K. 1990: Clinical significance of changes in the serum level of endogenous digitalis-like factor in patients with chronic congestive heart failure Zhonghua Nei Ke Za Zhi 29(1): 11-13; 59-60
Otto, C.W. 1986: Cardiovascular pharmacology. II: The use of catecholamines, pressor agents, digitalis, and corticosteroids in CPR and emergency cardiac care Circulation 74(6 Pt 2): Iv80-Iv85
Widimsky, J. 1975: Heart failure. Pathogenesis of heart failure and diagnosis of the incipient stage of heart failure Cor et Vasa 17(4): 302-314
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Schmidt, G.; Wirtzfeld, A.; Klein, G.; Sauer, E. 1981: Vasodilators in therapy-refractory heart insufficiency Zfa. Zeitschrift für Allgemeinmedizin 57(19): 1361-1366